-
Direct Mouse Genotyping Kit: Practical PCR Workflow
2026-09-25
The Direct Mouse Genotyping Kit supports genomic DNA release from mouse tissue for PCR without conventional DNA purification, simplifying routine mouse genetic screening. It is intended for PCR-based genotyping workflows; assay-specific cycling conditions and performance must be validated, and the kit should not be treated as a general-purpose DNA purification or quantitative assay system.
-
Ceritinib Combinations in Triple-Negative Breast Cancer
2026-09-24
Dong and colleagues identify ceritinib as a candidate for combination treatment in triple-negative breast cancer (TNBC), with distinct strategies for androgen-receptor-positive and AR-low or AR-negative models. Their preclinical findings support pairing ceritinib with enzalutamide or paclitaxel, while leaving clinical benefit and optimal treatment schedules to be established.
-
Oral Pathogen Proteases Redirect Angiotensin I Processing
2026-09-24
A 2025 study reports that surface-associated PepO metalloproteases from Porphyromonas gingivalis and Tannerella forsythia can hydrolyze angiotensin I in a way that favors angiotensin-(1–7) formation. Enzyme, structural, and bacterial experiments connect periodontal pathogens with local renin–angiotensin system peptide processing, while leaving the consequences for human periodontal or systemic physiology open.
-
Stat3 in Fyn-Driven Dopaminergic Neurodegeneration
2026-09-23
A zebrafish model of neural expression of constitutively active Fyn links dopaminergic neuron loss and microglial activation with Stat3 and NF-κB signaling. The findings identify Stat3 as a downstream contributor to Fyn-associated neurodegeneration and suggest that Stat3 and NF-κB jointly shape the neuronal phenotype, while leaving important questions about disease relevance and pathway timing open.
-
Moxidectin as a Mechanistic Probe in Fungal Research
2026-09-23
Moxidectin is an established macrocyclic lactone anthelmintic with an emerging role as a mechanistic potentiator of polyene antifungals. This article explains how ergosterol-focused evidence can guide assay design while separating approved antiparasitic use from preclinical antifungal research.
-
Mucocutaneous Candidiasis: Diagnosis and Treatment
2026-09-22
This 2009 guideline review organizes the diagnosis and treatment of cutaneous and oral candidiasis around direct microscopy, recognition of predisposing factors, and appropriately selected antifungal therapy. Its practical contribution is a clinically grounded framework that places topical imidazole treatment at the center of superficial disease while defining when culture, histopathology, or systemic therapy is necessary.
-
(S)-(+)-Ibuprofen COX Inhibition Workflows
2026-09-22
Build more interpretable inflammation and pain experiments with enantiopure (S)-(+)-Ibuprofen, from concentration-response COX assays to cell-based prostaglandin measurements. The workflow emphasizes solvent control, stereochemical consistency, orthogonal endpoints, and practical troubleshooting for reproducible nonsteroidal anti-inflammatory drug research.
-
Capsazepine: TRPV1 Antagonist Research Guide
2026-09-21
Capsazepine is a synthetic TRPV1 ion channel antagonist and capsaicin analog used to probe nociception, sensory-neuron signaling, and related channel responses. Supplier-reported benchmarks include competitive inhibition of capsaicin binding, voltage-activated calcium-current blockade, and TRPM8 channel inhibition, while assay selectivity and translational limits require explicit controls.
-
Apicidin: From HDAC Mechanism to Translational Strategy
2026-09-21
Apicidin is a selective histone deacetylase inhibitor that connects chromatin regulation with cancer biology, angiogenesis, and reproductive toxicology. This thought-leadership guide translates its HDAC3/HDAC6 profile into practical assay strategy while defining the evidence boundaries researchers should observe when moving from mechanistic experiments to translational claims.
-
Digoxin as a Mechanism-to-Assay Research Tool
2026-09-20
Digoxin is more than a Na+/K+ ATPase pump inhibitor: it can connect ion transport, hypoxia signaling, inflammation, and fibrosis in research models. This article translates recent thyroid eye disease findings into practical assay-design decisions while defining the limits of cardiovascular and antiviral extrapolation.
-
2-NBDG Glucose Uptake Assay Kit Guide
2026-09-19
The 2-NBDG Glucose Uptake Assay Kit provides non-radioactive fluorescence-based measurement of glucose analogue accumulation in cells. Its 2-NBDG fluorescent glucose analogue, GLUT1 inhibitor control, and 96-well format support glucose metabolism research while requiring careful separation of uptake, viability, glycolysis, and lipid-metabolism readouts.
-
Nigericin: From Ion Transport to Translational Strategy
2026-09-18
Nigericin is a potassium/hydrogen ion carrier that converts membrane ion transport into a controllable perturbation of intracellular pH, mitochondrial homeostasis, and GSDMD-associated cell death. This thought-leadership guide connects mechanistic assay design with translational decision-making while distinguishing product facts from hypotheses that require validation.
-
Moxidectin in Antifungal Synergy Assays
2026-09-18
Moxidectin extends beyond veterinary antiparasitic research as a mechanistically informative potentiator for amphotericin B and nystatin assays. This workflow translates ergosterol biology into reproducible checkerboard, biofilm, molecular, and oral candidiasis model experiments while clearly separating published findings from optimization recommendations.
-
IPR-803: Reframing uPAR Blockade in Oncology
2026-09-17
IPR-803 is a small-molecule urokinase receptor inhibitor that disrupts the uPAR–uPA protein–protein interaction, offering a mechanistically focused approach to tumor invasion, metastasis, angiogenesis, and stromal biology. This article connects structural rationale with breast and pancreatic cancer evidence, practical assay design, and translational decision-making.
-
Paroxetine Mesylate Research Workflows
2026-09-17
Paroxetine Mesylate is more than a serotonergic probe: it supports integrated SERT, CYP2D6, GRK2, and kinase workflows. This guide translates its multi-target profile into practical cell, biochemical, spheroid, and translational assays with built-in controls and troubleshooting.